Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2014
DOI: 10.1097/ta.0b013e3182ab1ab5
|View full text |Cite
|
Sign up to set email alerts
|

Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
117
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 151 publications
(124 citation statements)
references
References 23 publications
4
117
1
Order By: Relevance
“…This time point was chosen after analysis of the data from the Phase 2a study of AB103 [5] and on the definition of persistent inflammation and immunosuppression syndrome (PICS), defining patients with long duration (>14 d) ICU stays as the ones with complicated clinical outcomes as a result of persistent immune dysfunction and inflammation [13,14]. Resolution of mSOFA was stratified on the basis of the d 14 mSOFA score.…”
Section: Discussionmentioning
confidence: 99%
“…This time point was chosen after analysis of the data from the Phase 2a study of AB103 [5] and on the definition of persistent inflammation and immunosuppression syndrome (PICS), defining patients with long duration (>14 d) ICU stays as the ones with complicated clinical outcomes as a result of persistent immune dysfunction and inflammation [13,14]. Resolution of mSOFA was stratified on the basis of the d 14 mSOFA score.…”
Section: Discussionmentioning
confidence: 99%
“…Trauma is no different; severe traumatic injury is responsible for a major percentage of deaths worldwide [9]. Although advances in critical care have substantially improved the initial mortality associated with sepsis and trauma, many patients who survive the initial injury succumb from complications [10][11][12][13][14]. To date, immune modulation therapy and pharmacotherapeutic agents have proven disappointing in regards to modifying any human outcome, despite promising results from preclinical studies [15] Much of this preclinical work was done in rodent models [15].…”
Section: Introductionmentioning
confidence: 99%
“…First, in the absence of a universally agreed definition of PRMODS, our definitions are selected somewhat arbitrarily. Previous authors suggest that a ''complicated'' course of MODS may encompass a critical care stay of 7 to 10 days (6, 10) or a ''time to recovery'' of greater than 14 days (6,7,11). We elected to use an MODS duration of greater than 7 days to represent our PRMODS group as it appeared to capture patients at risk of particularly poor outcomes in terms of infection and mortality.…”
Section: Discussionmentioning
confidence: 99%
“…The second pattern describes patients whose MODS fails to recover, instead developing a prolonged or ''persistent'' course associated with long critical care unit stays, high rates of infection, and greater mortality (3,5). This form is described variably in the recent literature as ''persistant immunosuppression and protein catabolism syndrome (PICS)'' (5), ''cumulative'' MODS (3), or ''complicated'' MODS (6,7), although they all share prolonged critical care stays as a common feature. It remains unclear whether these two forms of MODS, here referred to as early resolving MODS (ERMODS) and prolonged MODS (PRMODS), are different clinical entities or are simply manifestations of different severity of physical and physiological insults.…”
Section: Introductionmentioning
confidence: 99%